NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
David J Kerr
University of Oxford - Oxford / United Kingdom
Others
AD Scientific Index ID: 908366
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
David J Kerr's MOST POPULAR ARTICLES
1-)
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancerJP Neoptolemos, DD Stocken, H Friess, C Bassi, JA Dunn, H Hickey, ...New England Journal of Medicine 350 (12), 1200-1210, 200430652004
2-)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialPM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ...The Lancet 396 (10249), 467-478, 202022602020
3-)
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trialHC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...The Lancet 394 (10193), 121-130, 201917702019
4-)
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision makingHJ Schmoll, E Van Cutsem, A Stein, V Valentini, B Glimelius, ...Annals of oncology 23 (10), 2479-2516, 201219202012
5-)
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.N Bhala, J Emberson, A Merhi, S Abramson, N Arber, JA Baron, ...Lancet (London, England) 382 (9894), 769-779, 201316872013
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept